PRESS RELEASE published on 02/26/2025 at 07:30, 1 year 8 months ago Evotec announces change in Management Board Evotec SE announces change in Management Board with Laetitia Rouxel stepping down as CFO and Paul Hitchin appointed as her successor. Rouxel to leave the Company on 31st March 2025. Hitchin brings over 20 years of finance leadership experience CFO Evotec SE Management Board Paul Hitchin Laetitia Rouxel
BRIEF published on 01/22/2025 at 07:35, 1 year 9 months ago Evotec Collaborates with Korean Entities on Novel Lung Disease Treatments Collaboration Grant Evotec Lung Disease Treatment Development
BRIEF published on 01/22/2025 at 07:35, 1 year 9 months ago Evotec collabore avec des entités coréennes sur de nouveaux traitements contre les maladies pulmonaires Collaboration Evotec Accorder Maladie Pulmonaire Développement De Traitement
PRESS RELEASE published on 01/22/2025 at 07:30, 1 year 9 months ago Evotec receives grant from Korean Government to develop novel antibody-based treatments for lung diseases Evotec SE receives US$ 4.5m grant from Korean Government to develop first-in-class therapeutic antibodies for lung diseases like asthma and idiopathic pulmonary fibrosis Evotec SE Grant Therapeutic Antibodies Lung Diseases Korean Government
BRIEF published on 12/11/2024 at 07:34, 1 year 11 months ago Evotec SE and Novo Nordisk Launch LAB eN² Projects for Drug Discovery Drug Discovery Evotec SE Novo Nordisk Cardiometabolic Diseases LAB EN²
BRIEF published on 12/11/2024 at 07:34, 1 year 11 months ago Evotec SE et Novo Nordisk lancent les projets LAB eN² pour la découverte de médicaments Evotec SE Découverte De Médicaments Novo Nordisk LAB EN² Maladies Cardiométaboliques
PRESS RELEASE published on 12/11/2024 at 07:29, 1 year 11 months ago Evotec SE announces first projects for LAB eN² drug discovery accelerator with Novo Nordisk Evotec SE announces selection of first projects for LAB eN² drug discovery accelerator with Novo Nordisk, focusing on cardiometabolic diseases from academic institutions Drug Discovery Evotec SE Novo Nordisk Cardiometabolic Diseases LAB EN²
BRIEF published on 11/29/2024 at 07:36, 1 year 11 months ago Evotec Announces COO Departure and Internal Restructuring Pharmaceuticals Management Change Evotec COO Departure Internal Restructuring
BRIEF published on 11/29/2024 at 07:36, 1 year 11 months ago Evotec annonce le départ de son directeur opérationnel et une restructuration interne Changement De Direction Evotec Médicaments Départ Du COO Restructuration Interne
PRESS RELEASE published on 11/29/2024 at 07:31, 1 year 11 months ago Evotec announces change in Management Board Evotec SE announces the departure of Chief Operating Officer Dr Craig Johnstone effective December 31, 2024, with internal distribution of responsibilities. Management praises Johnstone's contribution and commitment Global Operations Chief Operating Officer Evotec SE Management Board Dr Craig Johnstone
Published on 11/18/2026 at 00:35, 4 hours 11 minutes ago Route1 Appoints Tom Park to Board of Directors and Announces Board Changes
Published on 11/17/2026 at 23:40, 5 hours 6 minutes ago AI/ML Innovations Inc. Closes First Tranche of Private Placement
Published on 11/17/2026 at 23:00, 5 hours 46 minutes ago Alset AI Ventures Inc. Announces Extension of Annual General Meeting Deadline
Published on 11/17/2026 at 21:30, 7 hours 16 minutes ago Fairplay Ventures INC. Announces Filing of Filing Statement in Connection With Qualifying Transaction
Published on 11/17/2026 at 15:00, 13 hours 46 minutes ago Secure Blockchain's Agentic Solutions Signs Engineering Company, Expanding Enterprise AI Into Heavy Industry
Published on 11/18/2026 at 03:15, 1 hour 30 minutes ago China’s Recombinant Collagen Technology Wins the INPD Innovative Manufacturing Process Award
Published on 11/18/2026 at 03:15, 1 hour 30 minutes ago La technologie chinoise du collagène recombinant remporte le prix INPD du procédé de fabrication innovant
Published on 11/18/2026 at 01:55, 2 hours 50 minutes ago WIRobotics and Ottobock Join Forces to Expand Access to Wearable Robots Across North America
Published on 11/18/2026 at 01:40, 3 hours 5 minutes ago AMPERA and Berto Announce Proposed Business Combination to Accelerate Advanced Energy Technology Development and Commercialization
Published on 11/18/2026 at 00:59, 3 hours 47 minutes ago Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 11/17/2026 at 18:00, 10 hours 46 minutes ago 20261117 - Accor - Accor to increase its stake in Ennismore
Published on 11/17/2026 at 18:00, 10 hours 46 minutes ago Accor - Accor se renforce au capital de Ennismore
Published on 11/17/2026 at 17:45, 11 hours 1 minute ago EURAZEO COMPLETES THE SALE OF ITS STAKE IN AROMA-ZONE AND ITS REINVESTMENT ALONGSIDE PARTNERS GROUP
Published on 11/17/2026 at 17:45, 11 hours 1 minute ago EURAZEO FINALISE LA CESSION DE SA PARTICIPATION DANS AROMA-ZONE ET SON REINVESTISSEMENT AUX COTES DE PARTNERS GROUP
Published on 11/17/2026 at 07:40, 21 hours 5 minutes ago SUEZ INTERNATIONAL SAS COMPLETES THE SALE OF C.10.65 MILLION SHARES OF ACEA S.P.A.